Urgent.News

What's breaking now, across thousands of outlets.

Science

Connexin43 drives mitochondrial biogenesis and organelle stress in BRAF-mutant melanoma cells

Metabolic flexibility helps cancer cells survive targeted therapy, and BRAF-mutant melanoma rewires mitochondrial metabolism in response to BRAF/MEK inhibitors (BRAF/MEKi). We previously showed that connexin43 (Cx43) acts as a tumour suppressor in BRAF-mutant melanoma and enhances the response to BRAF/MEKi. Here, we investigated whether mitochondrial remodelling contributes to these effects. Cx43…

We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.

Read the original at biorxiv.org →

More in Science

More from Thursday 19 November →